Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

NCT00446329 is registered in ClinicalTrials.gov with Papageorgiou General Hospital as lead sponsor.

NCT NCT00446329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00446329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Lead sponsor
Papageorgiou General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2006
Completion date
Not reported
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary hyperparathyroidism